These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
793 related articles for article (PubMed ID: 33314005)
1. Host metabolism dysregulation and cell tropism identification in human airway and alveolar organoids upon SARS-CoV-2 infection. Pei R; Feng J; Zhang Y; Sun H; Li L; Yang X; He J; Xiao S; Xiong J; Lin Y; Wen K; Zhou H; Chen J; Rong Z; Chen X Protein Cell; 2021 Sep; 12(9):717-733. PubMed ID: 33314005 [TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery. Mulay A; Konda B; Garcia G; Yao C; Beil S; Villalba JM; Koziol C; Sen C; Purkayastha A; Kolls JK; Pociask DA; Pessina P; de Aja JS; Garcia-de-Alba C; Kim CF; Gomperts B; Arumugaswami V; Stripp BR Cell Rep; 2021 May; 35(5):109055. PubMed ID: 33905739 [TBL] [Abstract][Full Text] [Related]
3. Progenitor identification and SARS-CoV-2 infection in human distal lung organoids. Salahudeen AA; Choi SS; Rustagi A; Zhu J; van Unen V; de la O SM; Flynn RA; Margalef-Català M; Santos AJM; Ju J; Batish A; Usui T; Zheng GXY; Edwards CE; Wagar LE; Luca V; Anchang B; Nagendran M; Nguyen K; Hart DJ; Terry JM; Belgrader P; Ziraldo SB; Mikkelsen TS; Harbury PB; Glenn JS; Garcia KC; Davis MM; Baric RS; Sabatti C; Amieva MR; Blish CA; Desai TJ; Kuo CJ Nature; 2020 Dec; 588(7839):670-675. PubMed ID: 33238290 [TBL] [Abstract][Full Text] [Related]
4. Drug Inhibition of SARS-CoV-2 Replication in Human Pluripotent Stem Cell-Derived Intestinal Organoids. Krüger J; Groß R; Conzelmann C; Müller JA; Koepke L; Sparrer KMJ; Weil T; Schütz D; Seufferlein T; Barth TFE; Stenger S; Heller S; Münch J; Kleger A Cell Mol Gastroenterol Hepatol; 2021; 11(4):935-948. PubMed ID: 33186749 [TBL] [Abstract][Full Text] [Related]
5. Development of alveolar and airway cells from human iPS cells: toward SARS-CoV-2 research and drug toxicity testing. Tsuji K; Yamada S; Hirai K; Asakura H; Kanda Y J Toxicol Sci; 2021; 46(9):425-435. PubMed ID: 34470994 [TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Infection of Pluripotent Stem Cell-Derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response. Huang J; Hume AJ; Abo KM; Werder RB; Villacorta-Martin C; Alysandratos KD; Beermann ML; Simone-Roach C; Lindstrom-Vautrin J; Olejnik J; Suder EL; Bullitt E; Hinds A; Sharma A; Bosmann M; Wang R; Hawkins F; Burks EJ; Saeed M; Wilson AA; Mühlberger E; Kotton DN Cell Stem Cell; 2020 Dec; 27(6):962-973.e7. PubMed ID: 32979316 [TBL] [Abstract][Full Text] [Related]
7. Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium. Fiege JK; Thiede JM; Nanda HA; Matchett WE; Moore PJ; Montanari NR; Thielen BK; Daniel J; Stanley E; Hunter RC; Menachery VD; Shen SS; Bold TD; Langlois RA PLoS Pathog; 2021 Jan; 17(1):e1009292. PubMed ID: 33507952 [TBL] [Abstract][Full Text] [Related]
8. Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection. Ye ZW; Yuan S; Chan JF; Zhang AJ; Yu CY; Ong CP; Yang D; Chan CC; Tang K; Cao J; Poon VK; Chan CC; Cai JP; Chu H; Yuen KY; Jin DY Emerg Microbes Infect; 2021 Dec; 10(1):291-304. PubMed ID: 33538646 [TBL] [Abstract][Full Text] [Related]
9. Halting SARS-CoV-2: lung organoids step up to the plate. Leibel SL; Sun X EMBO J; 2021 Mar; 40(5):e107651. PubMed ID: 33576058 [TBL] [Abstract][Full Text] [Related]
10. An organoid-derived bronchioalveolar model for SARS-CoV-2 infection of human alveolar type II-like cells. Lamers MM; van der Vaart J; Knoops K; Riesebosch S; Breugem TI; Mykytyn AZ; Beumer J; Schipper D; Bezstarosti K; Koopman CD; Groen N; Ravelli RBG; Duimel HQ; Demmers JAA; Verjans GMGM; Koopmans MPG; Muraro MJ; Peters PJ; Clevers H; Haagmans BL EMBO J; 2021 Mar; 40(5):e105912. PubMed ID: 33283287 [TBL] [Abstract][Full Text] [Related]
11. Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A. White KM; Rosales R; Yildiz S; Kehrer T; Miorin L; Moreno E; Jangra S; Uccellini MB; Rathnasinghe R; Coughlan L; Martinez-Romero C; Batra J; Rojc A; Bouhaddou M; Fabius JM; Obernier K; Dejosez M; Guillén MJ; Losada A; Avilés P; Schotsaert M; Zwaka T; Vignuzzi M; Shokat KM; Krogan NJ; García-Sastre A Science; 2021 Feb; 371(6532):926-931. PubMed ID: 33495306 [TBL] [Abstract][Full Text] [Related]
12. Evolution of viral variants in remdesivir-treated and untreated SARS-CoV-2-infected pediatrics patients. Boshier FAT; Pang J; Penner J; Parker M; Alders N; Bamford A; Grandjean L; Grunewald S; Hatcher J; Best T; Dalton C; Bynoe PD; Frauenfelder C; Köeglmeier J; Myerson P; Roy S; Williams R; de Silva TI; Goldstein RA; Breuer J; J Med Virol; 2022 Jan; 94(1):161-172. PubMed ID: 34415583 [TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Infection and Disease Modelling Using Stem Cell Technology and Organoids. Trevisan M; Riccetti S; Sinigaglia A; Barzon L Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652988 [TBL] [Abstract][Full Text] [Related]
14. Activation of alveolar epithelial ER stress by β-coronavirus infection disrupts surfactant homeostasis in mice: implications for COVID-19 respiratory failure. Murthy A; Rodriguez LR; Dimopoulos T; Bui S; Iyer S; Chavez K; Tomer Y; Abraham V; Cooper C; Renner DM; Katzen JB; Bentley ID; Ghadiali SN; Englert JA; Weiss SR; Beers MF Am J Physiol Lung Cell Mol Physiol; 2024 Aug; 327(2):L232-L249. PubMed ID: 38860845 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system. Zhu Q; Zhang Y; Wang L; Yao X; Wu D; Cheng J; Pan X; Liu H; Yan Z; Gao L Antiviral Res; 2021 Mar; 187():105015. PubMed ID: 33444702 [TBL] [Abstract][Full Text] [Related]
17. Identification of SARS-CoV-2 inhibitors using lung and colonic organoids. Han Y; Duan X; Yang L; Nilsson-Payant BE; Wang P; Duan F; Tang X; Yaron TM; Zhang T; Uhl S; Bram Y; Richardson C; Zhu J; Zhao Z; Redmond D; Houghton S; Nguyen DT; Xu D; Wang X; Jessurun J; Borczuk A; Huang Y; Johnson JL; Liu Y; Xiang J; Wang H; Cantley LC; tenOever BR; Ho DD; Pan FC; Evans T; Chen HJ; Schwartz RE; Chen S Nature; 2021 Jan; 589(7841):270-275. PubMed ID: 33116299 [TBL] [Abstract][Full Text] [Related]
18. Human Organotypic Airway and Lung Organoid Cells of Bronchiolar and Alveolar Differentiation Are Permissive to Infection by Influenza and SARS-CoV-2 Respiratory Virus. Ekanger CT; Zhou F; Bohan D; Lotsberg ML; Ramnefjell M; Hoareau L; Røsland GV; Lu N; Aanerud M; Gärtner F; Salminen PR; Bentsen M; Halvorsen T; Ræder H; Akslen LA; Langeland N; Cox R; Maury W; Stuhr LEB; Lorens JB; Engelsen AST Front Cell Infect Microbiol; 2022; 12():841447. PubMed ID: 35360113 [TBL] [Abstract][Full Text] [Related]
19. 1'-Ribose cyano substitution allows Remdesivir to effectively inhibit nucleotide addition and proofreading during SARS-CoV-2 viral RNA replication. Zhang L; Zhang D; Wang X; Yuan C; Li Y; Jia X; Gao X; Yen HL; Cheung PP; Huang X Phys Chem Chem Phys; 2021 Mar; 23(10):5852-5863. PubMed ID: 33688867 [TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 promotes RIPK1 activation to facilitate viral propagation. Xu G; Li Y; Zhang S; Peng H; Wang Y; Li D; Jin T; He Z; Tong Y; Qi C; Wu G; Dong K; Gou J; Liu Y; Xiao T; Qu J; Li L; Liu L; Zhao P; Zhang Z; Yuan J Cell Res; 2021 Dec; 31(12):1230-1243. PubMed ID: 34663909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]